[Biomarker GDF-15 in cardiology]
- PMID: 34171946
[Biomarker GDF-15 in cardiology]
Abstract
GDF-15 (Growth differentiation factor 15) is a protein synthesised in some tissues including liver, kidney, heart, or lung. GDF-15 a stress-responsive cytokine. GDF-15 is emerging as a biomarker of cardiometabolic risk and disease burden. GDF-15 is linked to the incidence and prognosis of heart failure. In acute coronary syndromes GDF-15 identifies risk of complications including bleeding, reinfarction, development of heart failure or mortality. In patients with atrial fibrillation, GDF-15 is a potent marker of bleeding adverse events in anticoagulated patients and a predictor of overall mortality. Role of GDF-15 in cardiology is not definitively constituted.
Keywords: GDF-15; SGLT2; atrial fibrillation; biomarker; coronary artery disease; heart failure.
Similar articles
-
Growth differentiation factor 15 in heart failure: an update.Curr Heart Fail Rep. 2012 Dec;9(4):337-45. doi: 10.1007/s11897-012-0113-9. Curr Heart Fail Rep. 2012. PMID: 22961192 Review.
-
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.Circulation. 2014 Nov 18;130(21):1847-58. doi: 10.1161/CIRCULATIONAHA.114.011204. Epub 2014 Oct 7. Circulation. 2014. PMID: 25294786 Clinical Trial.
-
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.Circulation. 2010 Oct 5;122(14):1387-95. doi: 10.1161/CIRCULATIONAHA.109.928846. Epub 2010 Sep 20. Circulation. 2010. PMID: 20855664 Clinical Trial.
-
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.Open Heart. 2021 Mar;8(1):e001471. doi: 10.1136/openhrt-2020-001471. Open Heart. 2021. PMID: 33741689 Free PMC article.
-
GDF-15 as a Biomarker in Cardiovascular Disease.Arq Bras Cardiol. 2021 Mar;116(3):494-500. doi: 10.36660/abc.20200426. Arq Bras Cardiol. 2021. PMID: 33566936 Free PMC article. Review. English, Portuguese.
Cited by
-
Changes in transcriptomic landscape in human end-stage heart failure with distinct etiology.iScience. 2022 Feb 17;25(3):103935. doi: 10.1016/j.isci.2022.103935. eCollection 2022 Mar 18. iScience. 2022. PMID: 35252820 Free PMC article.
-
Association between Serum Galectin-3 and Growth Differentiation Factor-15 Levels and Coronary Slow Flow Phenomenon.Acta Cardiol Sin. 2023 Jul;39(4):572-579. doi: 10.6515/ACS.202307_39(4).20221128A. Acta Cardiol Sin. 2023. PMID: 37456936 Free PMC article.
-
Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2023 Nov 6;18:2431-2438. doi: 10.2147/COPD.S429334. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37955023 Free PMC article.
-
GDF-15 is a potential candidate biomarker for an elevated risk of cardiotoxicity in breast cancer patients receiving neoadjuvant dual anti-HER2 therapy.Front Pharmacol. 2024 May 17;15:1396133. doi: 10.3389/fphar.2024.1396133. eCollection 2024. Front Pharmacol. 2024. PMID: 38828460 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
